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Abstract. The intracellular transport and location of
major histocompatibility complex (MHC) class II mole-
cules and associated invariant chain (Ii) were investi-
gated in a human melanoma cell line. In contrast to
the class II molecules, which remain stable for >4 h
after synthesis, the associated Ii is proteolytically pro-
cessed within 2 h. During or shortly after synthesis
the N112-terminal cytoplasmic and membrane-spanning
segment is in some of the Ii molecules cleaved off; dur-
ing intracellular transport, class II associated and
membrane integrated Ii is processed from its COOH
terminus in distinct steps in endocytic compartments.
Immunocytochemical studies at the light and electron
microscopic level revealed the presence of class II
molecules, but not of Ii on the cell surface. Intracel-
M
AJOR histocompatibility complex (MHC)' class II
molecules consist of two nonidentical glycopro-
teins, the a-chain and 0-chain (for review, see
Cresswell et al., 1987) . They function in antigen presenta-
tion at the surface of a number of cells, including macro-
phages, B lymphocytes, and some tumor cells (Unanue,
1984) . Intracellularly, they are associated with the invariant
chain (Ii),' and this association occurs directly after inser-
tion into the endoplasmic reticulum (Jones et al., 1978 ; Kvist
et al., 1982). Ii is a transmembrane protein, exposing 30
NH2-terminal amino acids on the cytoplasmic side and
-160 amino acids on the lumenal side of the membrane
(Claesson et al., 1983).
The oligomeric complex of class II molecules and Ii is
thought to be transported to an endocytic compartment
where Ii dissociates from the complex and class II molecules
are then transported further to the plasma membrane (Koch
et al., 1989; Long, 1989; Neefjes et al., 1990). Ii remains
largely intracellularly and is eventually degraded (Owen et
al., 1981) . Degradation ofIi can partially be inhibited by the
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lularly both Ii and class II molecules were localized in
three morphologically and kinetically distinct compart-
ments, early endosomes, multivesicular bodies, and
prelysosomes. This localization in several distinct
endosomal compartments contrasts with the localiza-
tion of class II molecules in mainly one endocytic
compartment in B lymphoblastoid cell lines. As in
these lymphoblastoid cell lines Ii is known to be rapidly
degraded it is conceivable that the rate of proteolysis
of the class II associated Ii and its dissociation from
class II molecules modulates the retention of the oligo-
meric complex in endocytic compartments, and as a
consequence the steady-state distribution of these mol-
ecules within the endosomal system .
addition ofthe lysosomotropic agent chloroquine or the pro-
tease inhibitor leupeptin (Nowell and Quaranta, 1985; Blum
and Cresswell, 1988; Nguyen et al ., 1989).
The class II associated Ii has been implicated in the regula-
tion ofpeptide association to class II molecules (Koch et al.,
1989; Long et al., 1989). Two distinct functions ofIi in this
process have been proposed. First, Ii could prevent MHC
class II molecules from binding peptide prematurely in the
endoplasmic reticulum or Golgi complex (Elliott et al.,
1987; Roche and Cresswell, 1990). This was suggested from
the finding that peptide binding to class II molecules was re-
ducedin the presence of Ii or its lumenal segment (Roche and
Cresswell, 1990; Teyton et al., 1990). Second, the associa-
tion of Ii with class II molecules may regulate the localiza-
tion ofthese molecules in endocytic compartments. This was
supported by the finding that the cytoplasmic tail of Ii con-
tains a sorting signal for endosomes (Bakke and Dobber-
stein, 1990; Lotteau et al., 1990).
It has recently been shown, that in the B lymphoblastoid
cell line JY class II molecules were localizedto a distinct late
endosomal, lysosome related compartment (Peters et al.,
1991). Ii could only be found in the endoplasmic reticulum,
Golgi, and trans-Golgi network. The failure to detect Ii in
endocytic compartment may reflect the rapid degradation of
Ii in B lymphoblastoid cell lines (Blum and Cresswell, 1988;
Nguyen et al., 1989) .
MHC class II molecules expressed in transfected murine
L cellswere also shown tobe locatedin a late endocytic com-partment (Salamero et al ., 1990). As this location was inde-
pendent on the expression of Ii, it was suggested that MHC
class II molecules themselves may contain targeting informa-
tion for endosomal compartments (Salamero et al ., 1990).
We show here that in a humanmelanoma cell line, in con-
trast to these previous studies, class II molecules and Ii are
localized in three distinct endocytic compartments: early en-
dosomes, multivesicular bodies and prelysosomes. In con-
trast to B lymphoblastoid cells, in which Ii is degraded rap-
idly (Blum and Cresswell, 1988; Nguyen et al., 1989), the
class II-associated Ii in these melanoma cells is proteolyti-
cally processed at a slow rate. This proteolytic cleavage gives
rise to several polypeptides which remain associated with
class II molecules for >4 h after synthesis and all retain the
cytoplasmic tail shown previously to contain endosomal
sorting information (Bakke and Dobberstein, 1990; Lotteau
et al., 1990). Our results suggest that the localization of
MHC classII molecules in the endosomal system can depend
on the cell type and possibly on the rate ofprocessing of the
class II associated Ii and its dissociation from MHC class II
molecules.
Materials andMethods
Materials
Materials were obtained from the following sources: [35S]methionine (sp
act 1,300 Ci/mM) and 1°C-methylated protein standards were obtained
from Amersham International, Àmersham, England; protein A-Sepharose
was from Pharmacia LKB, Uppsala, Sweden; leupeptin, chymostatin, pep-
statin A, aprotinin, and PMSF were from Sigma Chemical Co., St. Louis,
MO; endoglycosidase H was from Seikagaku Kogyo Co., LTD, Tokyo,
Japan; Neuraminidase (type V) was from Sigma Chemical Co.
Cells and CellCulture
The human melanoma cell line Mel JuSo was a gift from Dr. Johnson (In-
stitut fur Immunologie Munich, Germany), and described before (Johnson
et al., 1981). The cells were cultured in RPMI 1640 medium supplemented
with 5% fetal calf serum (RPMI-FCS).
Antibodies
Hybridoma cells L-243 secreting anti-HLA-DR antibodies (Lampson and
Levy, 1980) were obtained from the American Type Culture Collection
(Rockville, MD). Ascites fluid was obtained by culturing the cells in-
traperitonally in BALB/c mice. Antiserum 311, a polyclonal antiserum
against the a-chain of class II molecules (Sege et al., 1981) was a kind gift
of Dr. P. A. Peterson. The polyclonal antisera against fusion proteins of
ß-galactosidase and parts ofIi expressed in NFl bacteria were described be-
fore (Lipp and Dobberstein, 1986; Wraight etal., 1990). Antisera recogniz-
ing an Ii NH2-terminal portion were raised against a fusion protein con-
taining the NH2-terminal 73 amino acids (Iil-73) of Ii and ß-galactosidase
(anti-IiN); antisera recognizing an Ii COOH-terminal portion were raised
against a fusion protein containing amino acids 73-216 of Ii (Ií73-216) and
ß-galactosidase (anti-IiC); VIC Yl (Quaranta et al., 1984) is a mouse
monoclonal antibody that recognizes an epitope within the NH2-terminal
30, cytosolic, amino acids of Ii (Wraight et al., 1990), and was a kind gift
from Dr. W. Knapp. Clonab LN2 (Biotest AG, Dreieich, Germany) is a
mouse monoclonal antibody recognizing an epitope at the outer 000H-
terminal portion of Ii (within amino acids 157-216 of Ii; Wraight et al.,
1990). AB4, amouse monoclonal anti-HLA-DR antibody (Kvalheirn et al .,
1988) was a kind gift from Dr. Funderud. Rabbit polyclonal antiserum
against the (cation-independent) mannose-6-phosphate receptor (MPR)
(Griffithsetal., 1988) was agift from Dr. Hoflack. Rabbitpolyclonal antise-
rum against the Golgi enzyme galactosyl transferase (anti-Gal Tf) (Berger
et al., 1987) was a gift from Dr. E. Berger.
MetabolicLabeling
Cells were grown on tissue culture dishes, and before labeling the medium
was replaced by methionine-free medium. After 1 h this medium was
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replaced by methionine-free medium containing 0.075 mCi/ml [35S]methi-
onine. After 20 min, the radioactive medium was removed, the cells were
washed twice in RPMI-FCS containing 2 mM methionine and incubated at
37°C in the same medium.
At thetimesindicated, the dishes wereplaced on ice, washed three times
with ice-cold PBS andthe cells were lysed in 20 mM Hepes pH 7.5 contain-
ing 100 mM NaCl, 5 mM MgC12, 1% Triton X-100, and 20,uM PMSF.
After 10-min incubation on ice, the cell lysates were collected and cen-
trifuged at 13,000 g for 15 min to remove cell debris.
Immunoprecipitation andElectrophoresis
Cell lysates from 1 x 106 cells were incubated with antibody at 4°C for
12 h, followed by the additionof40 Al protein A-Sepharose (1:1 slurry) and
further incubation for 2 h. The beads were washed twice with 1 ml of low
salt buffer (10 mM Tris-HC1 pH 7.5, 150 mM NaCl, 0.2 % NP-40, and 2
mM EDTA), twice with 1 ml ofhigh salt buffer (10 mM Tris-HCI pH 7.5,
500 mM NaCI 0.2% NP-40 and 2 mM EDTA), and twice with 1 nil of 10
mM Tris-HC1 pH7.5. For sequential immunoprecipitation ofantigens, anti-
body L-243 was used for the immunoprecipitation ofthe class II molecules
and associated proteins. This complex was then denatured by boiling the
protein A-Sepharose beads in 0.5% SDS and 1 mM ß-mercaptoethanol for
7 min. The sample was diluted 10-fold, and the second immunoprecipita-
tion was carried out as described above. The antigens were eluted from the
proteinA-Sepharose beads bythe addition ofsample buffer, denatured, and
subjected to SDS-PAGE (10-15 %)according to Laemmli (1970), fluorogra-
phy, and autoradiography.
Immunofluorescence Microscopy
Immunofluorescence on live cells was essentially performed as described
by Bakke and Dobberstein (1990). Briefly, viable cells grown on coverslips
were incubated on ice with the appropriate antibody to label antigens on
the plasma membrane. Then, the cells were fixed using 3 % paraformalde-
hyde, washed, and the cell surface molecules were visualized using FITC
or Texas Red-conjugated second antibody. To also label intracellular mole-
cules, cells were fixed with methanol for 4 ntin at -20°C, washed, and la-
beled using antibodies and fluorescein or Texas Red-conjugated second an-
tibody as described in the figure legends. After labeling, coverslips were
mounted in Mowiol, and examined using a Leitz Orthoplan fluorescence
photo-microscope equipped with a 63x objective and filters for fluorescein
or Texas Red.
Electron Microscopy
For the localization ofclass II molecules and Ii at the EM level, cells were
prepared for cryosectioning, and immunolabeled with antibodies against
class II molecules followed by 9-nm gold-conjugated protein A (Geuze et
al., 1981).
To identify the various compartments of the endocytic pathway, cells
were allowed to internalize different markers, essentially as described by
Parton et al. (1989) .
For the identification of early endosomes, HRP (10 mg/ml) was allowed
to be internalized for 5 or 10 min followed by chase periods up to 30 min
to label endosome transport vesicles and the prelysosomas. The HRP was
subsequently visualized using anti-HRP antibodies on cryosections, fol-
lowed by 5 nm protein A-gold complex.
For the identification oflysosomes, a 16-nm BSA-gold complex was in-
ternalized for 4 h at 37°C followed by an overnight chase in medium free
of BSA-gold. Under this condition the marker distributes between the
mannose-6-phosphate receptor (MPR)-enriched prelysosomal compart-
ment (PLC), and the MPR-negative lysosomes, (Griffiths et al., 1988,
1990). These cells were prepared for cryosectioning and immunolabeled
with antibodies followed by 5 and 9 nm protein A-gold (Griffiths et al.,
1984), as specified in the figure legends.
For quantitation, cells labeled for endocytic compartments were pre-
pared forcryosectioning, and immunolabeled for Ii using anti-IiN followed
by 9 nm protein A-gold. Quantitation of the amount of 9 run gold particles
on these cryosections was essentially carried out as described by Griffiths
and Hoppeler (1986) .
Results
Cleavage ofIiduring Intracellular Transport
Ii has previously been shown to dissociate from class II mol-
1214Figure 1. Ii associated with class II molecules is proteolytically processed during intracellular transport . Mel JuSo cells were incubated
with [35S]methionine for 20 min, then washed and chased for the times indicated. Proteins were immunoprecipitated with anti-class II
antibody (L-243 ;A) . The immunoadsorbed protein complexes were denaturedand reprecipitated with anti-IiC antiserum (B), or anti-IiN
antiserum (C) . In C, P22, P18, and P12 represent 22-, 18-, and 12-kD Ii-related proteins, respectively. In C, an asterisk indicates forms
of Ii which probably have acquired complex type carbohydrates . Shown are autoradiographs after SDS-PAGE and fluorography.
ecules during intracellular transport (Kvist et al ., 1982 ;
Machamer and Cresswell, 1982) . To determine the fate of
the class II-associated Ii, pulse-chase studies were per-
formed . Mel JuSo cells were labeled for 20 min and chased
for the times indicated in Fig . 1 . Proteins were immunopre-
cipitated with anti-class II antibody (L-243). SDS-PAGE
analysis and autoradiography reveal that after 1-h chase,
class II aand ßchains acquired complex type carbohydrates,
as judged by their reducedmobility in SDS-PAGE (Fig . 1 A) .
Several polypeptides are associated with the class II mole-
cules throughout thechase . To determinewhetherthese pro-
teins are immunologically related to li, we denatured the
complex by boiling in SDS and ß-mercaptoethanol . This
proceduredissociates the complex into separate polypeptide
Figure2 . Proteolytic processing of class II-associated Ii to P18 and P12, but not to P22 is inhibited by leupeptin, Mel JuSo cells were
incubated with 0.3 mM leupeptin 4 h before laöeling . Cells were pulse-labeled and chased for the times indicated in the presence of 0.3
mM leupeptin . Proteins were immunoprecipitated using anti-class II antibody L-243 (A) . The immunoadsorbed protein complexes were
denaturedand reprecipitated with anti-IiC antiserum (B), or anti-IiN antiserum(C) . In C, asterisks indicate forms of Ii that have acquired
complex type carbohydrates. Shown are autoradiographs after SDS-PAGE and fluorography.
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1215Figure 3 Plasma membrane immunolocalization of class II molecules and Ii in Mel JuSo cells . Cells grown on coverslips were labeled
on ice for class II molecules using mAb AB4 (A) or for Ii usingmAb LN2 (B), and a fluorescein-conjugated second antibody. Thereafter,
the cells were fixed with paraformaldehyde. C shows a phase-contrast photograph of the cells labeled for Ii shown in B. Bar, 20 Am.
chains. A subsequent immunoprecipitation, using antisera
recognizing either the lumenal Ii COOH-terminal portion
(anti-IiC) or the cytoplasmic Ii N112-terminal part (anti-
IiN), allows thus to identify Ii-related polypeptides associated
with class II molecules .
P25 results from an early cleavage in the endoplasmic
reticulum . It is not recognized by anti-EN but by anti-EC an-
tiserum (Fig . 1) . Therefore we conclude that P25 lacks the
N112-terminal region of Ii, most likely including the mem-
brane-spanning region . The amount of cell-associated P25
decreased during the chase and a portion of P25 can be de-
tected in the culture medium after 2-h chase (Fig . 1 B ; Pie-
ters, J., and B. Dobberstein, unpublished data) .
During the chase period, several small molecular mass
proteins appeared after 2 h in theMHC class II immunocom-
plexes (Fig . 1 A) . As Ii associated with class II molecules is
degraded during intracellular transport (Blum and Cress-
well, 1988 ; Nguyen and Humphreys, 1989), we suspected
that these small molecular weight proteins might be derived
from Ii .
Fig . 1, B and C shows that after denaturation of the class
II immunocomplexes and reprecipitation with Ii specific an-
tisera, the small molecular mass proteins are immunoprecip-
itated by the antiserum against the N112-terminal. part of Ii
(anti-EN), but not by the antiserum against the 000H-
terminal part (anti-IiC) (Fig . 1 C) . These small molecular
weight proteins have molecular masses of22 (P22), 18 (P18)
and 12 kD (P12) . As all these molecules react with anti-IiN
antiserum, which recognizes the extreme NH2-terminal
portion of Ii, these molecules must lack increasing portions
from the COON-terminal side . The amount ofP22 decreases
between 2 and 4 h of chase, whereas the amount of P12 in-
creases during the same time . This suggests that P22 is
processed sequentially to P18 and to P12 .
Effect ofLeupeptln on Ii Processing
The accumulation of P22, P18 and P12 after 2 h of chase and
the presence of complex type carbohydrates suggest that
cleavage of Ii occurs in a trans-Golgi or post-Golgi compart-
ment . It is known that at leastsome endocytic compartments
possess proteolytic activity (Kornfeld and Mellman, 1989 ;
Diment et al ., 1989) . Furthermore, it isknown that inB lym-
phoblastoid cells degradation of Ii can be inhibited by the ad-
dition of the protease inhibitor leupeptin (Blum and Cress-
well, 1988 ;Nguyen et al ., 1989) . To test whether proteolytic
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processing of Ii in Mel Juso cells occurs in an endocytic
compartment, we added leupeptin to the culture medium .
Cells were incubated for 4 h in the presence of 0.3 mM
leupeptin, labeled for 20 min and chased for the times indi-
cated in Fig . 2 . Proteins were immunoprecipitated using
anti-class II antibody (L-243), followed by denaturation and
immunoprecipitation using anti-IiC and anti-IiN antisera .
Fig . 2 shows that the incubation of the cells with leupeptin
resulted in accumulation of complexes of class II molecules
and P22 during the chase period . No processing to P18 and
P12 is seen (Fig . 2, A and C) . Leupeptin had, as expected,
no effect on the appearance of P25 (Fig . 2 B) .
Incubation of the cells in the presence of a cocktail of the
protease inhibitors leupeptin, chymostatin, and pepstatin A
did not prevent cleavage of Ii to P22 (data not shown) .
Localization of Class II Moleculesand Ii by
LightMicroscopy
The biochemical analysis of Ii chains assembled with class
II molecules strongly suggested their transport to an endo-
cytic, proteolytic compartment . To localize class II mole-
cules and Ii in Mel JuSo cells, we used immunofluorescence
microscopy.
Class II molecules are found at the plasma membrane in
Mel JuSo cells, and this is shown in Fig . 3 A . In contrast,
no Ii could be detected at the plasma membrane (Fig . B and
C), using the monoclonal antibody LN2, recognizing an epi-
tope located at the COON-terminal portion of Ii (Wraight et
al ., 1990) . After permeabilization of the cells this antibody
strongly labeled intracellularly located Ii molecules (results
not shown) .
As our biochemical data indicate that during intracellular
transport ofthe oligomeric complex of class II molecules and
Ii, the lumenal, COOH-terminal part of Ii is degraded, we
used antibodies against the NH2-terminal part of Ii in the
following studies . To analyze the localization ofIi in relation
to different markers of intracellular compartments, cells
were permeabilized and Ii was visualized using VIC Yl, an
antibody recognizing an N11 2-terminal, cytoplasmic deter-
minant (Wraight et al ., 1990) . Ii could be localized in the
perinuclear region and in a punctated pattern throughout
the cytoplasm (Fig. 4 A) . As reference, we used a marker for
the Golgi region . Cells were double labeled for Ii and galac-
tosyl transferase, a marker of the trans-Golgi (Berger et al .,
1987) (Fig . 4, A and B) . As can be seen in Fig . 4, A and B,
1216Figure 4 . Intracellular localization of Ii in MelJuSo cells . Cells grown on coverslips were fixed with methanol, and double labeled for
Ii (A) and galactosyl transferase (Gal Tf ; B), or for Ii (C), and the cation-independent manpose-6-phosphate receptor (MPR ; D) . Ii was
labeled with mAb VIC Yl anda FITC-conjugatedsecond antibody. Gal Tf andMPR were labeled with polyclonal antisera and visualized
using Texas Red-conjugated second antibody. Bar, 20 lam.
Ii is localized in the Golgi area, but also in other distinct
structures in the cell periphery.
Inhibition ofIi processing by leupeptin suggested transport
of the complex of class II molecules and Ii to an endocytic
compartment with proteolytic activity . As the (cation-inde-
pendent) marmose-6-phosphate receptor (MPR) is knownto
reside largely in a late endosomal compartment containing
proteolytic enzymes (i.e ., prelysosomes/late endosomes ;
Kornfeld andMellman,1989 ; Griffths et al ., 1988 ; Griffiths
et al ., 1990), we compared its location with that of Ii . Mel
JuSo cells were permeabilized and labeled for both Ii, using
VIC Yl, andMPR, using rabbit anti-MPR . As is depicted in
Fig. 4,CandD, some Ii seems to colocalize with the MPR,
but the bulk of the vesicular structures in which Ii is local-
ized, is MPR-negative .
Localization ofClassII Molecules and Ii at the
Electron Microscopy Level
To further characterize the compartments in which class IF
molecules and Ii are present, we used electron microscopy.
Endocytic compartments were identified by the internal-
ization ofHRPfor differenttimes(Parton et al ., 1989) . After
5 min of internalization, HRP is localized to the early en-
dosomes . After 10-15 min of internalization significant
amounts of HRP is also found in typical membrane rich,
spherical structures (Gruenberg et al ., 1989) . These struc-
tures are especially prominent in Mel JuSo cells, and show
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a multivesicular body like morphology, therefore, we name
them multivesicular bodies (MVB) . When HRP is pulsed for
10 min followed by a 30 min chase, HRP is then found dis-
tributed between the endosome transport vesicles and the
Table I . Amount of Ii Present in Double-labeled
Cryosections ofMel JuSo Cells as Determined by
Immunogold Labeling Using Anti-RN Antiserum
Followed by 9 nm Protein A-Gold`
The labeling ofthe plasma membrane (0.08 t0.01 gold per linear micrometer
for anti-IiN and 0.06 t 0.01 for anti-IiC) while low was over five times
higher than background (labeling with an irrelevant antibody gave 0.016
0.004 gold/Am plasma membrane .
' Thirty random profiles ofeach structure were counted, except for lysosomes
(n = 12).
$ Defined as HRP or 5 nm gold positive after 5 min internalization .
4 Membrane rich spherical structures: defined by characteristic morphology .
II MPR-enriched, containing 16 nm gold-BSA after 4-h label followed by
overnight chase .
1 MPR-negative, containing 16 nm gold-BSA after 4-h label followed by over-
night chase .
"" Defined by characteristic morphology .
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Compartment
Gold per
Anti-IiN
area organelle
Anti-IiC
Early endosomet 3.4 t 0.9 10.6 t 1 .4 gold/wm2
MVBs1E 5 .5 t 1 .2 4.0 t 0.5 gold/Am'
Prelysosomell 3.3 f 0.7 13.3 t 1 .8 gold/Am'
Lysosomel <0 .5 <0.5 gold/pmt
Golgi complex'* 4.7 t 1 .7 15.5 t 2.7 gold/wm2Table II. Amount ofMHC Class II Molecules Present in
Double-labeled Cryosections of Mel JuSo Cells as
Determined by Immunogold Labeling Using Antiserum
against the a-Chain followed by 9 nm Protein A-Gold*
* For experimental details see legend to Table 1.
t Gold particles present on the outer membranes only were quantitated.
MPR enriched PLC in BHK cells (Gruenberg et al., 1989) .
This could be confirmed for Mel JuSo cellsby double label-
ing with anti-MPR antibodies (not shown) . Lysosomes were
identified by the presence of 16 nM BSA-gold conjugate that
was given to the cells for 4 h followed by an overnight chase
(Grifffichs et al., 1990).
Mel JuSo cells in which various compartments of the en-
docytic pathway had been labeled as described above were
prepared for cryosectioning and antibody labeling. The
amount of Ii label on cryosections present in the various sub-
cellular compartments was quantified using anti-IiN and
anti-IiC antiserum, and the results are shown in Table I. Ii
was found to be present in early endosomes, late endosomes
or prelysosomes and MVBs. Very little Ii was found on the
plasma membrane.
The quantitative analysis of the labeling of Ii supports the
qualitative data showing similar amounts in early endo-
somes, MVBs and prelysosomes, with negligible amounts in
lysosomes (cf. below) . To directly compare the amounts of
labeling between the different compartments it is necessary
to assume that the labeling efficiencies are the same, that is
that each antibody has equal access to antigen in the different
structures. This may not always be the case (Griffiths and
Hoppeler, 1986) and the relatively lower labeling with
anti-IiC in the MVBs, for example, may reflect less access
of this antibody to the antigen. Alternatively, part of the
MVB population may already contain proteolytic activity
which leads to degradation ofIi COOH-terminal fragments
(see Figs. 1 and 2). Nevertheless, takentogether the data for
both antibodies suggest that the amount ofIi in the early en-
dosome, MVB and prelysosome is similar.
Examples ofintracellular compartments which are Ii posi-
tive are shown in Fig. 5. Fig. 5 A shows a typical early endo-
some (Grifcchs et al ., 1990; Gruenberg et al ., 1989) in
which the lumen is clearly labeled with Ii and HRP, taken
up by the cells for 10 min. Also present in this figure is a
multivesicular body, in which both the HRP and Ii can be
visualized. Fig. 5 B shows two of these MVBs, labeled with
both Ii and internalized HRP
Immunofluorescence microscopy indicated some colocal-
Figure S Localization of Ii in endocytic compartments (A and B). Mel JuSo cells were allowed to internalize HRP for 10 min to label
endocytic compartments. Cryosections were prepared and double labeled with anti-IiN and 9 tun gold (arrowhead) and anti-HRP and
5 nm gold (arrow) . (A) Labeling of early endosomes as well as MVBs with Ii and HRP (B) Labeling of MVBs with Ii and HRP. (C)
Cryosections of Mel JuSo were double labeled with anti-IiC and 9-nm gold (arrowhead) and anti-MPR and 5-nm gold (arrows) . Shown
are MVBs and prelysosomes with Ii and MPR. (*) Indicate MVBs; (P) plasma membrane; (G) Golgi complex; (V) unlabeled MVB; (N)
nucleus. Bars, 100 wn.
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ization of Ii and MPR. This finding was also supported by
electron microscopy. Fig. 5 C shows colocalization of Ii with
MPR in structures which most probably represent a prelyso-
some. Also MVBs are shown containing both Ii and MPR.
In addition, a MVB is indicated devoid of both Ii and MPR.
The plasma membrane, as expected, is unlabeled.
As class II molecules and Ii remain associated in Mel Juso
cells for >4 h after synthesis and Ii does not appear on the
plasma membrane, we were also interested to localize class
II molecules in intracellular compartments. Intracellular
compartments were identified in a similar manner as de-
scribed above for Ii.
The amount of class II labeling on cryosections present in
the various subcellular compartments was quantitated using
the anti-a-chain antiserum. The results are presented in 1ä-
ble II. To be able to compare directly the amount of label
on the plasma membrane with that over internal structures
we expressed the class II labeling on a per linear micrometer
scale. The plasma membrane, as expected, abundantly con-
tained class II molecules; furthermore, the class II mole-
cules were found to be present in equal amounts in the early
endosomes, MVBs, and prelysosomes. Lysosomes contained
a low but significant amount of class II molecules, whereas
the Golgi complex was poorly labeled . The significance of
this low Golgi labeling is not known .
Micrographs showing examples of class II molecules
localized in the various compartments are shown in Figs. 6
and 7. Fig. 6 A shows colocalization of class II molecules
with HRP endocytosed for 5 min in an early endosome. Fig.
7, A and B show localization of class II molecules on the
plasma membrane (P) and in MPR-rich compartments pre-
sumed to be prelysosomes. Some of these vesicular struc-
tures were also labeled with a 16 run gold-BSA complex
given to the cells for 4 h and then chased overnight. Not all
MVBs which were found positive for class II molecules were
also found positive for MPR. This is particular evident in
Fig. 7 B, which shows two MVBs devoid of MPR-specific
labeling and one which contains relatively large amounts of
MPR. Note also that MPR is mostly found at the internal
membranes of the MVBs whereas class II molecules are
nearly exclusively localized on the peripheral membrane.
The relative distribution ofthe class II molecules in the en-
docytic compartments and MVBs is very similar to the dis-
tribution of Ii as determined using anti-IiN and anti-IiC an-
tisera.
As apparently there are distinct populations of MVBs, as
judged by the absence or presence of MPR, we were in-
terested to see whether both Ii and class II molecules
colocalized to the same MVBs. Fig. 6 B shows that indeed
Ii and class II molecules can be identified within the same
MVB.
Discussion
In this study we analyze the intracellular transport and loca-
Compartment Anti-a-chain
Plasma membrane 9.8 t 1 .3 gold/gm
Early endosome 5.9 f 1 .4 gold/gm
MVBBt 5.6 t 2.1 gold/Wm
Prelysosomet 4.8 t 0.9 gold/pm
Lysosome 1.7 f 0.4 gold./jura
Golgi complex 0.2 f 0.05 gold/pmFigure 6 . (A) Localization of class II molecules in early endosomes . Mel JuSo cells were incubated with HRP for 5 min . Cryosections
were prepared and labeled with antibody against the a-chain ofclass II (Ab 311) and 9-run gold (smallarrowhead), and an antibody against
HRP and 5 nm gold (small arrows). Large arrowheads indicate the limiting membranes . (B) Colocalization of class II molecules and Ii
in a typical multivesicular body. Cryosections of Mel JuSo cells were labeled with an antibody against the a chain of class II molecules
(Ab . 311) and 5-nm gold (arrows), and anti-IiN antiserum and 9 run gold (arrowheads) . Bar, 100 nm .
tion of MHC class II molecules and associated invariant
chain in a human melanoma cell line. We show that after
2 h, the class II-associated Ii is processed to distinct frag-
ments . This processing occurs from theCOOH terminus and
results in the formation ofP22, P18, and P12, each represent-
ing a different segment of the N11 2-terminal part of Ii (Fig .
8) . As complex type carbohydrates can be detected on the
class II molecules and intact Ii already after 1 h of synthesis,
this suggests that cleavage from the Ii COON terminus oc-
curs in a post-Golgi compartment. In addition, incubation of
the cells in the presence of leupeptin prevented cleavage of
Ii to P18 and P12, but not to P22 . This indicates that P18 and
P12 are generated in an endosomal compartment (Fig . 8) . As
processing ofIi to P22 could notbe prevented by the addition
of several other protease inhibitors, this cleavage either oc-
curs in a compartment distinct from the endocytic pathway,
or is insensitive to the protease inhibitors used .
Studies from several laboratories have shown, that in con-
trast to Mel JuSo cells, no COOH-terminal proteolytically
processed forms were observed inB lymphoblastoid cells in
the absence of protease inhibitors (Kvist et al ., 1982 ; Blum
and Cresswell, 1988 ; Nguyen et al ., 1989) . Only in their
presence could P22 (P21, LIP) and P12 (P10) be detected
(Nguyen et al ., 1989 ; Blum and Cresswell, 1988) . This sug-
gests that in Mel JuSo cells either intracellular transport of
class II molecules and Ii is relatively slow, or that these cells
lack or contain very low amounts of certain proteases . Ex-
periments in which distinct endosomal proteases are added
to the cells may allow to discriminate between these possi-
bilities .
At the light microscopy level, Ii appeared to be present in
vesicular structures throughout the cell and in particular in
the Golgi area . Some colocalization of MPR and Ii was
found . Electron microscopy analysis showed that both Ii and
class II molecules are present in three distinct compartments
of the endocytic pathway : the early endosomes, membrane-
rich spherical compartments (MVBs), and prelysosomes .
Both Ii and class II molecules were found largely at the pe-
Figure 7 . Localization ofclass II molecules on the plasma membrane, in MVBs and lysosomes ; colocalization of class II molecules with
MPR in some compartments . Cryosections were prepared of Mel JuSo cells that had internalized 16-nn gold-BSA for 4 h followed by
an overnight chase in normal medium . This marker together withMPR defines prelysosomes and lysosomes. The sections were double
labeled with an antibody against the a-chain of class II molecules (Ab . 311) and 9-nm gold (arrows) and anti-MPR antibody and 5-nm
gold (small arrowheads) . In both A and B the bulk of the class II labeling is seen on the plasma membrane (P) . In A there is extensive
colocalization ofclass II molecules and MPR in many vesicularprofiles, one of which contains the internalized 16-nm gold (large arrow) .
In B three MVBs are seen (*) . In all class II molecules can be found, almost exclusively on the peripheral membrane . One of these mul-
tivesicular bodies (upper one) has significant MPR labeling and may therefore have already fused with the prelysosomal compartment .
A profile ofthe latter is evident in the bottom left part ofthe figure, in which also class II molecules can be localized . The large arrowhead
indicates a lysosome containing class II labeling . Bars, 100 nm .
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Figure 8. Schematic representation ofthe processing steps of class
II associated Ii at various stages of intracellular transport in Mel
JuSo cells . ot and 0 represent the «-chain and the 0-chain ofMHC
class II molecules, respectively ; -o, represents carbohydrate side
chains ; P25, P22, P18, and P12 represent processed forms of Ii . In
theER class II molecules (a/3) are found associated with membrane
integrated Ii and with an NH2-terminal deletion of Ii, P25 . During
intracellular transport Ii is proteolytically processed to P22, P18,
and P12 . Processing ofP22 to P18 and P12 can be inhibited by cul-
turing cells in medium containing the protease inhibitor leupeptin.
On the plasma membrane class II molecules can be found but very
little Ii .
riphery of the MVBs in contrast to MPR which was found
more in the centre of these organelles . The functional
significance of this differential distribution in the MVB re-
mains to be elucidated but may be related to their different
fates (Felder et al., 1990) .
The presence of class II molecules in a late endocytic,
lysosome-related compartment has recently been demon-
strated in the B lymphoblastoid cell line JY (Peters et al .,
1991) . Ii was not detected in endocytic compartments, proba-
bly due to the rapid degradation ofIi in lymphoblastoid cells
(Blum and Cresswell, 1988 ; Nguyen et al., 1989) . Using a
different lymphoblastoid cell line, Guagliardi et al . (1990)
localized class II molecules and Ii in an early endocytic com-
partment .
Clearly in Mel JuSo cells we find a different distribution
of class II molecules and Ii . Both of these molecules are
found in early as well as late endosomes, and, in addition in
MVBs . In contrast to the rapid degradation of Ii in B lym-
phoblastoid cell lines, Ii NH2-terminal fragments remain
associated with class II molecules >4 h after synthesis inMel
JuSo cells . As the NH2-terminal cytoplasmic fragment of Ii
has been shown to contain a sorting signal for endosomal
compartments (Bakke and Dobberstein, 1990 ; Lotteau et
al ., 1990), the steady-state location of class II molecules in
a given cell line might depend on the rate of processing of
Ii and on the dissociation of Ii from class II molecules.
In transfected mouse L cells, Salamero et al . (1990)
showed that class II molecules can be found in late endo-
somes independent of the expression of Ii . This would sug-
gest that class II molecules may contain themselves targeting
information for late endosomes. It remains to be established
which pathway is followed by class II molecules to endocytic
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compartments . Depending on the cell type, class II mole-
cules may enter the endosomal system directly from the
trans-Golgi network en route to the plasma membrane
(Neefjes et al ., 1990), or by internalization after being trans-
ported to the plasma membrane (Reid and Watts, 1990) . At
present, the relative contributions of the signals in Ii and
class II molecules to the followed pathway to endosomes are
not known .
The association of Ii or its NH2-terminal fragments with
class II molecules might also modulate the distribution of
these molecules in the endosomal system . This would ex-
plain the finding that class II molecules expressed in cells in
which Ii is rapidly degraded (e.g ., lymphoblastoid cell lines)
are localized in late endosomes/prelysosomes only (Peters et
al ., 1991) . Our results, using a melanoma cell line, suggest
that prolonged association of Ii or its NH2-terminal frag-
ments may be responsible for the localization ofclass II mol-
ecules in several distinct endosomal compartments . Differ-
ences in Ii proteolysis in different cell lines may therefore
explain the apparent discrepancy in class II localization de-
scribed before (Guagliardi et al., 1990 ; Peters et al., 1991) .
We conclude that knowledge of the type of Ii molecules at
various stages oftransport in a given cell line may be essen-
tial for understanding transport and localization ofMHC
class II molecules .
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